Search

Search Constraints

You searched for: Author/Creator Blyth, Emily

Search Results

1. An atypical case of Epstein–Barr virus‐positive plasma cell post‐transplant lymphoproliferative disorder successfully treated with adoptive cell therapy. (28th June 2021)

2. Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell. Issue 1 (24th January 2023)

6. Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant. Issue 1 (20th May 2022)

7. Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection. Issue 10 (21st October 2020)

9. Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance. Issue 10 (13th May 2020)

10. Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells. Issue 7 (2nd July 2020)